Model Details

Patient Information for Model: BCM-15030

Patient Information
Clinical Timeline

Color Keys:
 
 Positive
 
 Negative
 
 N/A

Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-15030

Biomarkers & Mutations
Model Details
Mutations (Cancer Gene Census List)
There are no omics data for this model.

CNV


Histology Information for Model: BCM-15030

Patient

PDX

H&E

ER

PR

HER2


Metastasis Information for Model: BCM-15030
 
Patient
PDX
Abdomen
Anterosuperior mediastinum
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Hip
Kidney
Leg bone
Liver
Lung
Lymph Node
Mediastinum
Neck
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural Cavitiy
Pleural effusion
Posterior cervical nodes
SVC node
Skin
Thymus

Patient Treatment Information for Model: BCM-15030

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
10Fluorouracil, Doxorubicin, CyclophosphamideAdjuvant34.4234.75120 daysNot ReportedNot ApplicableTreatment Completed
20Other, TamoxifenRecurrent/Metastatic43.5948.761887 daysNot ReportedNot ApplicableDisease Progression
25Goserelin, AnastrozoleRecurrent/Metastatic49.0949.1833 daysNot ReportedNot ApplicableSide Effects
30Megestrol acetateRecurrent/Metastatic49.2655.522285 daysNot ReportedNot ApplicableDisease Progression
35FulvestrantRecurrent/Metastatic55.5256.77456 daysNot ReportedNot ApplicableDisease Progression
40LetrozoleRecurrent/Metastatic56.8557.0262 daysNot ReportedNot ApplicableDisease Progression
45TamoxifenRecurrent/Metastatic57.157.1829 daysNot ReportedNot ApplicableTreatment Completed
50OophorectomyRecurrent/Metastatic57.1857.18UnknownNot ReportedNot ApplicableTreatment Completed
55AnastrozoleRecurrent/Metastatic57.1957.77212 daysNot ReportedNot ApplicableDisease Progression
60Everolimus, ExemestaneRecurrent/Metastatic57.8358.0891 daysNot ReportedNot ApplicableSide Effects
65Palbociclib, LetrozoleRecurrent/Metastatic58.158.68212 daysNot ReportedNot ApplicableDisease Progression
70Radiation Therapy (RT)Recurrent/Metastatic58.6858.8147 daysNot ReportedNot ApplicableTreatment Completed
75AnastrozoleRecurrent/Metastatic58.7759.52274 daysNot ReportedNot ApplicableDisease Progression
80CapecitabineRecurrent/Metastatic59.6161.0507 daysNot ReportedNot ApplicableCurrent Treatment
95High-dose estrogenMetastatic60.961.037 daysProgressive DiseaseNot ApplicableDisease Progression












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.